tazarotene has been researched along with Dyslipidemias in 1 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence." | 1.56 | Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. ( Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menter, A | 1 |
| Cordoro, KM | 1 |
| Davis, DMR | 1 |
| Kroshinsky, D | 1 |
| Paller, AS | 1 |
| Armstrong, AW | 1 |
| Connor, C | 1 |
| Elewski, BE | 1 |
| Gelfand, JM | 1 |
| Gordon, KB | 1 |
| Gottlieb, AB | 1 |
| Kaplan, DH | 1 |
| Kavanaugh, A | 1 |
| Kiselica, M | 1 |
| Kivelevitch, D | 1 |
| Korman, NJ | 1 |
| Lebwohl, M | 1 |
| Leonardi, CL | 1 |
| Lichten, J | 1 |
| Lim, HW | 1 |
| Mehta, NN | 1 |
| Parra, SL | 1 |
| Pathy, AL | 1 |
| Farley Prater, EA | 1 |
| Rupani, RN | 1 |
| Siegel, M | 1 |
| Stoff, B | 1 |
| Strober, BE | 1 |
| Wong, EB | 1 |
| Wu, JJ | 1 |
| Hariharan, V | 1 |
| Elmets, CA | 1 |
1 other study available for tazarotene and Dyslipidemias
| Article | Year |
|---|---|
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiov | 2020 |